chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fast heart rate/ the same night, her heart rate was 62 beats per minute which is faster than normal for her/ climbed up to the 70s and 80 and during the day it was mostly between 84-110 beats per minute/ heart rate peaked at 128 beats per minute; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Fast heart rate/ the same night, her heart rate was 62 beats per minute which is faster than normal for her/ climbed up to the 70s and 80 and during the day it was mostly between 84-110 beats per minute/ heart rate peaked at 128 beats per minute) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (The patient had lost her sense of taste and smell and experienced an increase in heart rate as well) on 17-Dec-2020, Heart rate increased (Heart rate in the 120s. It has happened once or twice before that as well. ) in January 2020 and Left bundle branch block (Diagnosed with approximately 10 years ago) in 2011. Concomitant products included LOSARTAN, LEVOTHYROXINE, CETIRIZINE, FAMOTIDINE, SIMVASTATIN, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), BIOTIN, COLECALCIFEROL (VITAMIN D3), LORAZEPAM and BEVACIZUMAB (AVASTIN [BEVACIZUMAB]) for an unknown indication.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TACHYCARDIA (Fast heart rate/ the same night, her heart rate was 62 beats per minute which is faster than normal for her/ climbed up to the 70s and 80 and during the day it was mostly between 84-110 beats per minute/ heart rate peaked at 128 beats per minute). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 08-Mar-2021, TACHYCARDIA (Fast heart rate/ the same night, her heart rate was 62 beats per minute which is faster than normal for her/ climbed up to the 70s and 80 and during the day it was mostly between 84-110 beats per minute/ heart rate peaked at 128 beats per minute) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Dec-2020, SARS-CoV-2 test: positive (Positive) Positive. On 06-Mar-2021, Heart rate: 62 (High) 62 beats per minute, climbed up to the 70s and 80. On 07-Mar-2021, Heart rate: 84-110 (High) 84-110 beats per minute and 128 (High) 128 beats per minute.         Concomitant medication also included unspecified Probiotic   This case was linked to MOD-2021-395703 (Patient Link).
BODY ACHES; FELT TIRED; FEVER; This spontaneous report received from a patient via a company representative . The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The company was unable to perform follow up to request batch number. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, felt tired, and fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, felt tired, and fever. This report was non-serious.
Information has been received on 31-OCT-2018 regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, a pharmacist administered the ZOSTAVAX vaccine to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In 2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries.  The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Patient received pfizer vaccine on 3/6/21, 4/19/21 and 10/7/21. Presented to ER on 5/10/22. Took home COVID19 test which was positive on 5/7/22. On 5/10/22 in hospital, COVID19 was negative. He presented with  upper respiratory infection type symptoms with coughing mainly present for about 8 days prior to coming to the hospital.  Four days prior had taken at home COVID test was positive.  He was concerned because he was having some shortness of breath so came to the emergency department.  Workup was negative.  He had elevation in his troponin which is chronic.  Did not have any corresponding cardiac issues.  Coughing was minimal.  He was not hypoxic.  He tested negative at the hospital for COVI D. Nonetheless was isolated and monitored overnight.  He was started on ceftriaxone and azithromycin.  Pan cultures obtained and followed.  They were negative.  On the above date he was totally asymptomatic and tolerating activity.  Was retested for COVID and again negative.  He was discharged home in stable condition. on  5/11/22
Extreme nausea, chills, body aches, headache, tiredness, diarrhea for 4 days.
She kinda knew she wasn't with it but not really /really don't know what to do. She didn't know what she wanted for breakfast; She seemed a little confused; She seemed a little off; Fever of 99.8; You could tell something was off; A spontaneous report was received from Consumer and Healthcare Professional concerning a patient 98 years old , female and who received Moderna's COVID-19 vaccine(mRNA-1273) and experienced a little confusion, she seemed a little off, you could tell something was off, memory impairment and fever. It is a serious case; Seriousness criteria: Hospitalization  The patient's medical history was not provided. The patient's lab data was provided- did a CAT scan, chest x-ray, urine sample (which was negative). Everything was clear. Concomitant products were not provided.  On 12 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Batch Number unknown) via unknown route on left arm for prophylaxis of COVID-19 infection. The patient waited 15 min after shot. (it was Friday at 1:00) she was fine Friday and Saturday and Sunday morning. She seemed a little confused and didn't know how the remote(to her recliner) worked. She seemed a little off. She really don't know what to do. She didn't know what she wanted for breakfast.  She didn't know how to use her nose drops (caller states her mother had difficulty expressing this). The consumer stated that "This woman is very sharp." I put her thru some memory test. she couldn't tell me (her birthday), you could tell something was off. She didn't know how to use the phone, TV remote, remote for recliner, she wasn't really talking from Sunday. Took her to ER at hospital they did a CAT scan, chest x-ray, she had a fever 99.8, urine sample (which was negative). everything was clear. They kept her for observation overnight. Thursday her doctor (through her insurance) wanted to come check her out. He gave her a memory test. She was coming into herself again and she remembered the 3 words. We then handed her the phone (which she was able to use). Within half an hour of him arriving she was completely fine (last Thursday) and has continued to be. Caller states regrading her mother she "kinda knew she wasn't with it but not really." They called the patients neurologist and they said it should clear up in 10days regarding her side effects.  Treatment provided was unknown.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the events she seemed a little confused, She seemed a little off, you could tell something was off, she kinda knew she wasn't with it but not really  were Not Resolved / Not recovered and for  fever were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
pt says she and her friends got teeth sensitivity and pain like a toothache that lingers. was more frequent before but now more like once a month.
5JUN96 arm sore;7JUn not feeling well arm more sore;10JUN96 has gotten cont worse, stomach ache;dark tan triangle around inj site;
A patient was given expired Fluzone Quadrivalent/No AE; Initial information was received on 15-Sep-2020 regarding an unsolicited non-serious case received from a other health care professional.  This case involves patient (unknown demographics) who received expired dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UJ244AA and expiry date 30-Jun-2020) via unknown route at unknown administration site prophylactic vaccination on an unknown date (expired product administered).  It was an actual medication error case due to expired vaccine used (latency: same day). Vaccine was expired on 30-Jun-2020.  At a time of reporting no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
I felt a fullness in my chest.  I took my blood pressure several times with digital blood pressure machine. Readings were:131/93 p.165,  142/94 p.162, 135/93 p.150,  155/87 p.102, 139/84 p. 98, 120/76 p.78
Employer received flu vaccine left arm 10/30/2003 in AM. Complained of pain in right arm in afternoon and went to the ER.  No redness or swelling noted.  MD believes it is neuropathy of brachiol pleause.  To go to neurologist.
Patient has pain on shoulder and claims it is due to the flu shot administered by a floater pharmacist.
Irregular period: extended period/spotting over 3+ weeks ever since vaccine without any changes to birth control.
First injection (4/1/21))--Bursitis in Left shoulder flared up--unable to lift left arm, left arm went numb (painful/stuck); immediate reaction.  Fibrous cysts in both right and left breasts.  Started period shortly after (1 day of brown spotting, 3 days of red blood), achy-ness, cramping, bloating, fatigue, hot flashes, pain.   Second injection (4/28/21)-- stopped hydrocortisone, only took liothyronine--not synthroid, stopped bio-identical hormone for 5 days prior to 2nd shot, drank copious amounts of water. Injected on Right side.  Waited 6 hours, then took Tylenol for aches/pains.  Sweating, hot flashes  Starting in March, experienced blurry vision, vertigo, radiating pain to neck, numbness in fingertips and Left ankle, left side of face swelling, painful, inflamed, equilibrium off.  Hot flashes have gotten completely out of control.  Lots of shooting pains, running down back.     I was doing great before the vaccination.  Probably the healthiest I have ever been in years.
pt recv vax 12JUN97 & 4SEP97 pt devel hepatitis A characterized by fatigue, dark urine, jaundice & myalgia;22OCT97 pt recovered;
Little bit tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Little bit tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included NAPROXEN and ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FATIGUE (Little bit tired). At the time of the report, FATIGUE (Little bit tired) outcome was unknown. Not Provided          No Treatments were reported.
About 8 hours later, pain to injection site when moving arm and applying pressure. 24 hours later, feeling tired, weak, mild head pain joint/muscle pain and overly sick feeling.
we all get infected with a severe symptoms; we all get infected with a severe symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "we all get infected with a severe symptoms".  Additional Information: reporter stated that, have three children: 17-year-old son vaccinated. 15-year-old daughter vaccinated. 13-year-old son not vaccinated. For the second winter after got the vaccine we all get infected with a severe symptom but the non-vaccinated son. If you care about your business (let alone your families if you have any) then you may not neglect my message. I'm sure it was not a unique one. Forwarded, no medical inquiry asked.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
chills; rapid heartbeat 175+/rapid heartbeat; bad rash on torso; fever 100.0 f; nausea; brutal headache; muscle pain; tired; This is a spontaneous report from a contactable consumer (Patient). A 68-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number EM9551), via an Intramuscular route of administration in left arm on 12Feb2021 10:06 at single dose for COVID-19 immunization. Patient medical history known allergies: Penecillin, Seasonal allergy, hay fever, and COVID. Past Drug Event included Aspirin and Tylenol for Known allergies. Concomitant medication included flonase allergy relief for allergies, atorvastatin, tadalafil, prilosec, and elder flower. He had a bad rash all over his torso 12 hours in. He clarifies later the rash could have been almost 24 hours after the injection. The rash has slightly improved. The caller also experienced a very rapid heartbeat of about 177. He also had a fever for about 24 hours. Caller states his rapid heartbeat was consistent with the fever and chills. He confirms these symptoms started about 12 hours after receiving the injection. Patient underwent lab test and procedural included Body temperature 100.0 Fahrenheit, Heart rate 177.The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected
Inappropriate Reconstitution Technique; Inappropriate dose of vaccine administered; Injection site redness; Injection site swelling; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number H2HM2, expiry date 29th August 2021) and (batch number NE3TG, expiry date 10th August 2021) for prophylaxis.   On 11th June 2019, the patient received Shingrix. On 11th June 2019, the dose was .5 ml (.5 ml daily). On 11th June 2019, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were reported as follows: The pharmacist stating, she was experienced at administering Shingrix vaccine.  The patient was given the second dose of the Shingrix vaccine but was initially injection only the adjuvant into the left arm, deltoid region. The pharmacist realized the error and mixed another batch of the antigen with the day of reporting and injected it also into the left arm, deltoid region intramuscularly, but about an inch lower to same day of first injection site. The batch number for Shingrix antigen (batch number H2HM2, expiry date 29th August 2021) and Adjuvant (batch number NE3TG, expiry date 10th August 2021) reported only for recovery dose (corrective action). Batch number was not reported for 1st dose of Shingrix vaccine which was incorrectly prepared.   Follow up information received from pharmacist on 22nd July 2019:  The patient had no known drug allergies. The patient returned to pharmacy 5 days later the adjuvant injection site had no visible reaction. On 11th June 2019, the patient received the 2nd dose of Shingrix 0.5 ml intramuscularly.  In June 2019, the patient experienced injection site erythema and injection site swelling.  On an unknown date, the outcome of the injection site erythema and injection site swelling was resolved with sequelae.  It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix.  There was light redness and swelling at Shingrix injection site. The patient stated she did not experience any systemic reactions like fever and illness. It was a medication error with adverse drug reaction.
client  complained of headache and lightheaded approximately 15 mins after receiving the 1st dose of Pizer Covid vaccine (lot#EW0150 Exp 4/3/21). EMT responded. First vitals at 1138: blood pressure 140/90, pulse 65, oxygen 100%, respiration 18. Client alert and oriented, no medical condition at this time, medications are just daily vitamins, B12, Vit D, magnesium and zinc. Allergy to  sulfa medication. PHN  joined EMT. Per client symptoms started at 1114 but did not inform staff until later. Client reported to PHN feeling flushed, PHN offered benadryl. Client declined, asked to contact husband first since she drove alone. At 1141 client asked to use restroom, EMT accompanied client to outside of restroom. Client was able to walk with steady gait, no complaints. 1145 client stated she would wait the remaining 30 min observation and report if headache worsened. Client decided to not take benadryl after speaking with husband. Lightheaded feeling and flushing had resolved. EMT stayed with client. Client advised to speak with provider prior to second dose. ER precautions given. Last set of vitals at 1150: blood pressure 130/ 80, oxygen 100%, pulse 70.
VARICELLA VACCINE GIVEN 10/25/04- PATIENT COMPLAINS OF HEADACHE X 6 DAYS POST INJECTION. DAY 2 PT. COMPLAINED HEADACHE SEVERE, MOTHER GAVE MOTRIN, TOOK TO ER.
No adverse symptoms reported; Inappropriate schedule of vaccine administered; This spontaneous report was received from a physician, concerning a 12-year-old patient of unknown gender.  Information on concurrent conditions, medical history and concomitant medications were not reported.   On 19-OCT-2016, the patient received the first dose of same patient received second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. The patient received the second dose on 21-DEC-2016, and was in the office on 09-SEP-2020, and would be receiving a third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). No adverse symptoms reported.
Heart attack; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: MYOCARDIAL INFARCTION (death, medically significant), outcome "fatal", described as "Heart attack". The patient date of death was unknown. Reported cause of death: "heart attack". It was not reported if an autopsy was performed.  Additional information: The reporter has lost family members from it they have died. They have tried, they reported to VAERS, already reported the deaths. They were on there and then they were scrubbed or taken off because they didn't find it was an actual Pfizer or vaccine death. One died of a heart attack, one died of stroke, and they said, no they died of a heart attack and a stroke not a Pfizer shot even though it was just 3 weeks after.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: heart attack
Mom reported shaking, possible seizure activity within 30 minutes of multiple injections. RN witnessed similar episode of extremity twitching after BS done.
Approximately 10 minutes after vaccination, patient came up to pharmacy counter and reported feeling light headed, dizzy, having blurred vision, headache and chills. Patient had significant high blood pressure after taking her blood pressure with an automatic cuff. She also appeared disoriented and anxious. Emergency services were called but patient refused transport to the emergency room.
noticed  approx 4 dot rash spots on right hip and had leg pain then developed a few more spots  on upper back of right thigh had burning thigh pain when tried to sleep at night and most nights after diagnosed only able to sleep approx 1 1/2   hr before  awakened by burning leg pain. treated with valtrex, gabapentin, ibuprofen.  lasted about 10 days , rash now dry. also had some white  sores in mouth  on right side of gum and developed  small fever blister on right side of lip.
Arm infected - fever, chills, painful, rash. Pt. stated she had cellulitis and treated pt with antibiotics. Pt. stated no SOB.
Redness (size of half dollar) "hot" to touch and with discomfort, minimal swelling visible.
Information has been received from an allergist concerning a 4 year old male patient with food allergies, who on 05-SEP-2010 was vaccinated with a dose MMR II (Lot number not reported). The allergist reported that on 05-SEP-2010 the patient had an anaphylactic reaction. The patient complained of itching, scratching and could not breath immediately following the vaccination with MMR II. It was reported that the patient visited an emergency room but was not admitted. A recent skin test was performed with sterile diluent that produced a positive skin test. BENADRYL and epinephrine were given as a treatment for the experience. The patient recovered on an unspecified date. Anaphylactic reaction was considered to be immediately life-threatening by the allergist. Additional information has been requested.
Fever and chills 10 hours after injection Pain at injection site immediately after  Headache, fatigue, muscle soreness 24 hours after